227 related articles for article (PubMed ID: 16452202)
21. Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK.
Liu DP; Wang Y; Koeffler HP; Xie D
Int J Oncol; 2007 Apr; 30(4):865-71. PubMed ID: 17332925
[TBL] [Abstract][Full Text] [Related]
22. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.
Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B
Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491
[TBL] [Abstract][Full Text] [Related]
23. Invasive behaviour of human gliomas is mediated by interindividually different integrin patterns.
Tonn JC; Wunderlich S; Kerkau S; Klein CE; Roosen K
Anticancer Res; 1998; 18(4A):2599-605. PubMed ID: 9703915
[TBL] [Abstract][Full Text] [Related]
24. Gene expression of neural cell adhesion molecule L1 in malignant gliomas and biological significance of L1 in glioma invasion.
Izumoto S; Ohnishi T; Arita N; Hiraga S; Taki T; Hayakawa T
Cancer Res; 1996 Mar; 56(6):1440-4. PubMed ID: 8640837
[TBL] [Abstract][Full Text] [Related]
25. Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness.
Lemke D; Pfenning PN; Sahm F; Klein AC; Kempf T; Warnken U; Schnölzer M; Tudoran R; Weller M; Platten M; Wick W
Clin Cancer Res; 2012 Jan; 18(1):105-17. PubMed ID: 22080438
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of 67LR reduces the migratory activity of human glioma cells in vitro.
Chen FX; Qian YR; Duan YH; Ren WW; Yang Y; Zhang CC; Qiu YM; Ji YH
Brain Res Bull; 2009 Aug; 79(6):402-8. PubMed ID: 19446013
[TBL] [Abstract][Full Text] [Related]
27. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
Hoelzinger DB; Demuth T; Berens ME
J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.
Correa TC; Brohem CA; Winnischofer SM; da Silva Cardeal LB; Sasahara RM; Taboga SR; Sogayar MC; Maria-Engler SS
J Cell Biochem; 2006 Sep; 99(1):156-67. PubMed ID: 16791855
[TBL] [Abstract][Full Text] [Related]
29. ECM-mediated glioma cell invasion.
Goldbrunner RH; Bernstein JJ; Tonn JC
Microsc Res Tech; 1998 Nov; 43(3):250-7. PubMed ID: 9840803
[TBL] [Abstract][Full Text] [Related]
30. Contactin is expressed in human astrocytic gliomas and mediates repulsive effects.
Eckerich C; Zapf S; Ulbricht U; Müller S; Fillbrandt R; Westphal M; Lamszus K
Glia; 2006 Jan; 53(1):1-12. PubMed ID: 16078236
[TBL] [Abstract][Full Text] [Related]
31. Brain slice invasion model reveals genes differentially regulated in glioma invasion.
Holtkamp N; Afanasieva A; Elstner A; van Landeghem FK; Könneker M; Kuhn SA; Kettenmann H; von Deimling A
Biochem Biophys Res Commun; 2005 Nov; 336(4):1227-33. PubMed ID: 16171788
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
[TBL] [Abstract][Full Text] [Related]
33. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK
Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763
[TBL] [Abstract][Full Text] [Related]
34. Proteomic characterization of inter-alpha inhibitor proteins from human plasma.
Josic D; Brown MK; Huang F; Lim YP; Rucevic M; Clifton JG; Hixson DC
Proteomics; 2006 May; 6(9):2874-85. PubMed ID: 16596706
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of a transmembrane isoform of neural cell adhesion molecule alters the invasiveness of rat CNS-1 glioma.
Owens GC; Orr EA; DeMasters BK; Muschel RJ; Berens ME; Kruse CA
Cancer Res; 1998 May; 58(9):2020-8. PubMed ID: 9581848
[TBL] [Abstract][Full Text] [Related]
36. Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity.
Wu FY; Wang SE; Sanders ME; Shin I; Rojo F; Baselga J; Arteaga CL
Cancer Res; 2006 Feb; 66(4):2162-72. PubMed ID: 16489017
[TBL] [Abstract][Full Text] [Related]
37. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.
Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B
Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157
[TBL] [Abstract][Full Text] [Related]
38. Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity.
Amberger VR; Hensel T; Ogata N; Schwab ME
Cancer Res; 1998 Jan; 58(1):149-58. PubMed ID: 9426071
[TBL] [Abstract][Full Text] [Related]
39. The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress.
Höring E; Harter PN; Seznec J; Schittenhelm J; Bühring HJ; Bhattacharyya S; von Hattingen E; Zachskorn C; Mittelbronn M; Naumann U
Acta Neuropathol; 2012 Jul; 124(1):83-97. PubMed ID: 22249620
[TBL] [Abstract][Full Text] [Related]
40. Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.
Kuan CT; Wakiya K; Dowell JM; Herndon JE; Reardon DA; Graner MW; Riggins GJ; Wikstrand CJ; Bigner DD
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1970-82. PubMed ID: 16609006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
